English
简体中文
Total: £ 56.28
Published Date: 2025-12-11 | Pages: 76 | Tables: 74 | Medical Care
The global market for Clinical Molecular Imaging System was valued at US$ 518 million in the year 2024 and is projected to reach a revised size of US$ 898 million by 2031, growing at a CAGR of 6.9% during the forecast period.
Molecular imaging (MI) is a medical imaging technology that combines multiple disciplines, such as medical imaging technology, molecular biology, radiology, computer science, etc., and performs imaging by detecting radioactive markers or other imaging probes in the human body. Molecular imaging systems are high-end products in the field of medical imaging, and the main market participants are internationally renowned medical equipment manufacturers. With the continuous advancement of technology and the increase in clinical needs, the market prospects for molecular imaging systems are broad. In the future, digital technology, artificial intelligence algorithms, etc. will further enhance the performance and clinical application value of molecular imaging systems.In terms of the industry chain, the upstream involves the research and development of probes and tracers, the supply of radioisotopes/labels, and the manufacturing of detectors and core imaging devices; the midstream involves the supply of complete imaging systems (including hardware and software); and the downstream provides services and applications for hospitals, imaging diagnostic centers, and pharmaceutical/research institutions.The industry's gross profit margin is approximately 40-60%.
The main market drivers for clinical molecular imaging systems include:
Rising Disease Burden and Demand for Personalized Medicine
With the increasing aging of the global population, changing lifestyles, and environmental factors, the incidence of chronic and major diseases such as cancer, cardiovascular disease, neurological disorders, and metabolic syndrome continues to rise. This has led to a growing demand in healthcare systems for early detection, precise diagnosis, and monitoring of treatment response. Traditional imaging (such as CT and MRI) focuses primarily on structural changes, often revealing symptoms only after disease progression. Molecular imaging systems, however, can capture disease processes at the molecular or cellular level, enabling early diagnosis. Therefore, clinical institutions, imaging centers, and pharmaceutical R&D are increasingly willing to deploy molecular imaging systems that support pre-treatment, during-treatment, and post-treatment monitoring. Furthermore, with the rise of precision medicine, targeted therapy, and immunotherapy, imaging systems must possess higher sensitivity and earlier sign-capturing capabilities in scenarios such as patient segmentation, efficacy evaluation, and recurrence monitoring. As a result, the "molecular probe + imaging system + analysis service" combination offered by system manufacturers has ushered in a market expansion opportunity.
Technological innovation and improved imaging performance promote adoption. From a technical perspective, molecular imaging systems have experienced rapid development in recent years. Typical examples include the increasingly mature hybrid modalities of PET/SPECT and CT/MRI (e.g., PET-CT, PET-MR), which improve localization accuracy and diagnostic value by fusing functional images with anatomical structural images. ([Grand Vision Research][1]) Upgrades in detector materials, improvements in image reconstruction algorithms, artificial intelligence (AI)-assisted analysis, increased data processing speed, shorter scan times, and improved comfort are all enhancing user experience and clinical usability. ([Research and Markets][2]) Furthermore, the research and development of molecular imaging tracers and probes is constantly deepening, making imaging with more targets, higher sensitivity, and lower doses possible. While the technical threshold and equipment complexity are high, this very high level of complexity also constitutes a barrier to market entry, giving manufacturers with existing technological, channel, and service capabilities an advantage. Furthermore, emerging technologies such as long-axis field-of-view (LAFOV) PET/CT are expanding imaging capabilities, leading to a continuous broadening of clinical applications. ([arXiv][3]) Therefore, technological innovation provides a powerful driving force for system upgrades.
Expansion of Medical Infrastructure, Innovation in Service Models, and the Rise of Emerging Markets
From a macro perspective, multiple factors have converged to drive the market penetration of molecular imaging systems. First, many countries worldwide have increased healthcare spending, promoted the construction of medical infrastructure, and improved the configuration of imaging diagnostic centers, leading to increased demand for advanced imaging equipment in hospitals and diagnostic centers. Second, outside of hospitals, diagnostic service outsourcing, imaging centers, and clinical trial service companies are also increasingly emphasizing the capabilities of imaging systems, especially in new drug development and efficacy monitoring, where imaging has become a key link. ([Towards Healthcare][4]) Furthermore, emerging market countries (such as Asia, Latin America, and parts of the Middle East and Africa) have growth potential in terms of upgrading medical equipment and improving diagnostic capabilities. With their large populations, heavy disease burdens, and increased awareness of advanced imaging equipment, the market opportunities for molecular imaging systems are also growing. Finally, from a business model perspective, equipment manufacturers and service providers are shifting towards a "system + software + service" model. Image analysis platforms, quantitative tools, AI-assisted diagnosis, imaging service contracts, and remote support are becoming new value-added points, thereby increasing overall profitability and strengthening market appeal. In summary, the expansion of medical infrastructure, service model innovation, and the rise of emerging markets have collectively strengthened the market driving force of this system.
This report aims to provide a comprehensive presentation of the global market for Clinical Molecular Imaging System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Molecular Imaging System.
The Clinical Molecular Imaging System market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Clinical Molecular Imaging System market comprehensively. Regional market sizes, concerning products by Type, by Application, by Technology and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Clinical Molecular Imaging System companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Philips
GE Healthcare
Siemens
GMM
Hitachi
United-imaging
Shinva Medical
Kangda Medical
Wandong Medical
Canon Medical
Segment by Type
Fixed
Mobile
Segment by Technology
Radiological Nuclear Medicine Imaging
Magnetic Resonance Molecular Imaging
Optical Molecular Imaging
Other
Segment by Product Forms
PET Scanning Systems
Gamma Camera Systems
Hybrid Systems
Other
Segment by Application
Hospital
Clinic
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Technology etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Clinical Molecular Imaging System company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical Molecular Imaging System Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Fixed
1.2.3 Mobile
1.3 Market by Technology
1.3.1 Global Clinical Molecular Imaging System Market Size Growth Rate by Technology: 2020 VS 2024 VS 2031
1.3.2 Radiological Nuclear Medicine Imaging
1.3.3 Magnetic Resonance Molecular Imaging
1.3.4 Optical Molecular Imaging
1.3.5 Other
1.4 Market by Product Forms
1.4.1 Global Clinical Molecular Imaging System Market Size Growth Rate by Product Forms: 2020 VS 2024 VS 2031
1.4.2 PET Scanning Systems
1.4.3 Gamma Camera Systems
1.4.4 Hybrid Systems
1.4.5 Other
1.5 Market by Application
1.5.1 Global Clinical Molecular Imaging System Market Growth by Application: 2020 VS 2024 VS 2031
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Other
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Clinical Molecular Imaging System Market Perspective (2020-2031)
2.2 Global Clinical Molecular Imaging System Growth Trends by Region
2.2.1 Global Clinical Molecular Imaging System Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Clinical Molecular Imaging System Historic Market Size by Region (2020-2025)
2.2.3 Clinical Molecular Imaging System Forecasted Market Size by Region (2026-2031)
2.3 Clinical Molecular Imaging System Market Dynamics
2.3.1 Clinical Molecular Imaging System Industry Trends
2.3.2 Clinical Molecular Imaging System Market Drivers
2.3.3 Clinical Molecular Imaging System Market Challenges
2.3.4 Clinical Molecular Imaging System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clinical Molecular Imaging System Players by Revenue
3.1.1 Global Top Clinical Molecular Imaging System Players by Revenue (2020-2025)
3.1.2 Global Clinical Molecular Imaging System Revenue Market Share by Players (2020-2025)
3.2 Global Top Clinical Molecular Imaging System Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Clinical Molecular Imaging System Revenue
3.4 Global Clinical Molecular Imaging System Market Concentration Ratio
3.4.1 Global Clinical Molecular Imaging System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Molecular Imaging System Revenue in 2024
3.5 Global Key Players of Clinical Molecular Imaging System Head office and Area Served
3.6 Global Key Players of Clinical Molecular Imaging System, Product and Application
3.7 Global Key Players of Clinical Molecular Imaging System, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical Molecular Imaging System Breakdown Data by Type
4.1 Global Clinical Molecular Imaging System Historic Market Size by Type (2020-2025)
4.2 Global Clinical Molecular Imaging System Forecasted Market Size by Type (2026-2031)
5 Clinical Molecular Imaging System Breakdown Data by Application
5.1 Global Clinical Molecular Imaging System Historic Market Size by Application (2020-2025)
5.2 Global Clinical Molecular Imaging System Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Clinical Molecular Imaging System Market Size (2020-2031)
6.2 North America Clinical Molecular Imaging System Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Clinical Molecular Imaging System Market Size by Country (2020-2025)
6.4 North America Clinical Molecular Imaging System Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Clinical Molecular Imaging System Market Size (2020-2031)
7.2 Europe Clinical Molecular Imaging System Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Clinical Molecular Imaging System Market Size by Country (2020-2025)
7.4 Europe Clinical Molecular Imaging System Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Clinical Molecular Imaging System Market Size (2020-2031)
8.2 Asia-Pacific Clinical Molecular Imaging System Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Clinical Molecular Imaging System Market Size by Region (2020-2025)
8.4 Asia-Pacific Clinical Molecular Imaging System Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Clinical Molecular Imaging System Market Size (2020-2031)
9.2 Latin America Clinical Molecular Imaging System Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Clinical Molecular Imaging System Market Size by Country (2020-2025)
9.4 Latin America Clinical Molecular Imaging System Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clinical Molecular Imaging System Market Size (2020-2031)
10.2 Middle East & Africa Clinical Molecular Imaging System Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Clinical Molecular Imaging System Market Size by Country (2020-2025)
10.4 Middle East & Africa Clinical Molecular Imaging System Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Philips
11.1.1 Philips Company Details
11.1.2 Philips Business Overview
11.1.3 Philips Clinical Molecular Imaging System Introduction
11.1.4 Philips Revenue in Clinical Molecular Imaging System Business (2020-2025)
11.1.5 Philips Recent Development
11.2 GE Healthcare
11.2.1 GE Healthcare Company Details
11.2.2 GE Healthcare Business Overview
11.2.3 GE Healthcare Clinical Molecular Imaging System Introduction
11.2.4 GE Healthcare Revenue in Clinical Molecular Imaging System Business (2020-2025)
11.2.5 GE Healthcare Recent Development
11.3 Siemens
11.3.1 Siemens Company Details
11.3.2 Siemens Business Overview
11.3.3 Siemens Clinical Molecular Imaging System Introduction
11.3.4 Siemens Revenue in Clinical Molecular Imaging System Business (2020-2025)
11.3.5 Siemens Recent Development
11.4 GMM
11.4.1 GMM Company Details
11.4.2 GMM Business Overview
11.4.3 GMM Clinical Molecular Imaging System Introduction
11.4.4 GMM Revenue in Clinical Molecular Imaging System Business (2020-2025)
11.4.5 GMM Recent Development
11.5 Hitachi
11.5.1 Hitachi Company Details
11.5.2 Hitachi Business Overview
11.5.3 Hitachi Clinical Molecular Imaging System Introduction
11.5.4 Hitachi Revenue in Clinical Molecular Imaging System Business (2020-2025)
11.5.5 Hitachi Recent Development
11.6 United-imaging
11.6.1 United-imaging Company Details
11.6.2 United-imaging Business Overview
11.6.3 United-imaging Clinical Molecular Imaging System Introduction
11.6.4 United-imaging Revenue in Clinical Molecular Imaging System Business (2020-2025)
11.6.5 United-imaging Recent Development
11.7 Shinva Medical
11.7.1 Shinva Medical Company Details
11.7.2 Shinva Medical Business Overview
11.7.3 Shinva Medical Clinical Molecular Imaging System Introduction
11.7.4 Shinva Medical Revenue in Clinical Molecular Imaging System Business (2020-2025)
11.7.5 Shinva Medical Recent Development
11.8 Kangda Medical
11.8.1 Kangda Medical Company Details
11.8.2 Kangda Medical Business Overview
11.8.3 Kangda Medical Clinical Molecular Imaging System Introduction
11.8.4 Kangda Medical Revenue in Clinical Molecular Imaging System Business (2020-2025)
11.8.5 Kangda Medical Recent Development
11.9 Wandong Medical
11.9.1 Wandong Medical Company Details
11.9.2 Wandong Medical Business Overview
11.9.3 Wandong Medical Clinical Molecular Imaging System Introduction
11.9.4 Wandong Medical Revenue in Clinical Molecular Imaging System Business (2020-2025)
11.9.5 Wandong Medical Recent Development
11.10 Canon Medical
11.10.1 Canon Medical Company Details
11.10.2 Canon Medical Business Overview
11.10.3 Canon Medical Clinical Molecular Imaging System Introduction
11.10.4 Canon Medical Revenue in Clinical Molecular Imaging System Business (2020-2025)
11.10.5 Canon Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Clinical Molecular Imaging System Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Fixed
Table 3. Key Players of Mobile
Table 4. Global Clinical Molecular Imaging System Market Size Growth Rate by Technology (US$ Million): 2020 VS 2024 VS 2031
Table 5. Key Players of Radiological Nuclear Medicine Imaging
Table 6. Key Players of Magnetic Resonance Molecular Imaging
Table 7. Key Players of Optical Molecular Imaging
Table 8. Key Players of Other
Table 9. Global Clinical Molecular Imaging System Market Size Growth Rate by Product Forms (US$ Million): 2020 VS 2024 VS 2031
Table 10. Key Players of PET Scanning Systems
Table 11. Key Players of Gamma Camera Systems
Table 12. Key Players of Hybrid Systems
Table 13. Key Players of Other
Table 14. Global Clinical Molecular Imaging System Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 15. Global Clinical Molecular Imaging System Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 16. Global Clinical Molecular Imaging System Market Size by Region (2020-2025) & (US$ Million)
Table 17. Global Clinical Molecular Imaging System Market Share by Region (2020-2025)
Table 18. Global Clinical Molecular Imaging System Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 19. Global Clinical Molecular Imaging System Market Share by Region (2026-2031)
Table 20. Clinical Molecular Imaging System Market Trends
Table 21. Clinical Molecular Imaging System Market Drivers
Table 22. Clinical Molecular Imaging System Market Challenges
Table 23. Clinical Molecular Imaging System Market Restraints
Table 24. Global Clinical Molecular Imaging System Revenue by Players (2020-2025) & (US$ Million)
Table 25. Global Clinical Molecular Imaging System Market Share by Players (2020-2025)
Table 26. Global Top Clinical Molecular Imaging System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Molecular Imaging System as of 2024)
Table 27. Ranking of Global Top Clinical Molecular Imaging System Companies by Revenue (US$ Million) in 2024
Table 28. Global 5 Largest Players Market Share by Clinical Molecular Imaging System Revenue (CR5 and HHI) & (2020-2025)
Table 29. Global Key Players of Clinical Molecular Imaging System, Headquarters and Area Served
Table 30. Global Key Players of Clinical Molecular Imaging System, Product and Application
Table 31. Global Key Players of Clinical Molecular Imaging System, Date of Enter into This Industry
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Clinical Molecular Imaging System Market Size by Type (2020-2025) & (US$ Million)
Table 34. Global Clinical Molecular Imaging System Revenue Market Share by Type (2020-2025)
Table 35. Global Clinical Molecular Imaging System Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 36. Global Clinical Molecular Imaging System Revenue Market Share by Type (2026-2031)
Table 37. Global Clinical Molecular Imaging System Market Size by Application (2020-2025) & (US$ Million)
Table 38. Global Clinical Molecular Imaging System Revenue Market Share by Application (2020-2025)
Table 39. Global Clinical Molecular Imaging System Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 40. Global Clinical Molecular Imaging System Revenue Market Share by Application (2026-2031)
Table 41. North America Clinical Molecular Imaging System Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. North America Clinical Molecular Imaging System Market Size by Country (2020-2025) & (US$ Million)
Table 43. North America Clinical Molecular Imaging System Market Size by Country (2026-2031) & (US$ Million)
Table 44. Europe Clinical Molecular Imaging System Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Europe Clinical Molecular Imaging System Market Size by Country (2020-2025) & (US$ Million)
Table 46. Europe Clinical Molecular Imaging System Market Size by Country (2026-2031) & (US$ Million)
Table 47. Asia-Pacific Clinical Molecular Imaging System Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 48. Asia-Pacific Clinical Molecular Imaging System Market Size by Region (2020-2025) & (US$ Million)
Table 49. Asia-Pacific Clinical Molecular Imaging System Market Size by Region (2026-2031) & (US$ Million)
Table 50. Latin America Clinical Molecular Imaging System Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 51. Latin America Clinical Molecular Imaging System Market Size by Country (2020-2025) & (US$ Million)
Table 52. Latin America Clinical Molecular Imaging System Market Size by Country (2026-2031) & (US$ Million)
Table 53. Middle East & Africa Clinical Molecular Imaging System Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 54. Middle East & Africa Clinical Molecular Imaging System Market Size by Country (2020-2025) & (US$ Million)
Table 55. Middle East & Africa Clinical Molecular Imaging System Market Size by Country (2026-2031) & (US$ Million)
Table 56. Philips Company Details
Table 57. Philips Business Overview
Table 58. Philips Clinical Molecular Imaging System Product
Table 59. Philips Revenue in Clinical Molecular Imaging System Business (2020-2025) & (US$ Million)
Table 60. Philips Recent Development
Table 61. GE Healthcare Company Details
Table 62. GE Healthcare Business Overview
Table 63. GE Healthcare Clinical Molecular Imaging System Product
Table 64. GE Healthcare Revenue in Clinical Molecular Imaging System Business (2020-2025) & (US$ Million)
Table 65. GE Healthcare Recent Development
Table 66. Siemens Company Details
Table 67. Siemens Business Overview
Table 68. Siemens Clinical Molecular Imaging System Product
Table 69. Siemens Revenue in Clinical Molecular Imaging System Business (2020-2025) & (US$ Million)
Table 70. Siemens Recent Development
Table 71. GMM Company Details
Table 72. GMM Business Overview
Table 73. GMM Clinical Molecular Imaging System Product
Table 74. GMM Revenue in Clinical Molecular Imaging System Business (2020-2025) & (US$ Million)
Table 75. GMM Recent Development
Table 76. Hitachi Company Details
Table 77. Hitachi Business Overview
Table 78. Hitachi Clinical Molecular Imaging System Product
Table 79. Hitachi Revenue in Clinical Molecular Imaging System Business (2020-2025) & (US$ Million)
Table 80. Hitachi Recent Development
Table 81. United-imaging Company Details
Table 82. United-imaging Business Overview
Table 83. United-imaging Clinical Molecular Imaging System Product
Table 84. United-imaging Revenue in Clinical Molecular Imaging System Business (2020-2025) & (US$ Million)
Table 85. United-imaging Recent Development
Table 86. Shinva Medical Company Details
Table 87. Shinva Medical Business Overview
Table 88. Shinva Medical Clinical Molecular Imaging System Product
Table 89. Shinva Medical Revenue in Clinical Molecular Imaging System Business (2020-2025) & (US$ Million)
Table 90. Shinva Medical Recent Development
Table 91. Kangda Medical Company Details
Table 92. Kangda Medical Business Overview
Table 93. Kangda Medical Clinical Molecular Imaging System Product
Table 94. Kangda Medical Revenue in Clinical Molecular Imaging System Business (2020-2025) & (US$ Million)
Table 95. Kangda Medical Recent Development
Table 96. Wandong Medical Company Details
Table 97. Wandong Medical Business Overview
Table 98. Wandong Medical Clinical Molecular Imaging System Product
Table 99. Wandong Medical Revenue in Clinical Molecular Imaging System Business (2020-2025) & (US$ Million)
Table 100. Wandong Medical Recent Development
Table 101. Canon Medical Company Details
Table 102. Canon Medical Business Overview
Table 103. Canon Medical Clinical Molecular Imaging System Product
Table 104. Canon Medical Revenue in Clinical Molecular Imaging System Business (2020-2025) & (US$ Million)
Table 105. Canon Medical Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
Table 109. Authors List of This Report
List of Figures
Figure 1. Clinical Molecular Imaging System Picture
Figure 2. Global Clinical Molecular Imaging System Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Clinical Molecular Imaging System Market Share by Type: 2024 VS 2031
Figure 4. Fixed Features
Figure 5. Mobile Features
Figure 6. Global Clinical Molecular Imaging System Market Size Comparison by Technology (2020-2031) & (US$ Million)
Figure 7. Radiological Nuclear Medicine Imaging Features
Figure 8. Magnetic Resonance Molecular Imaging Features
Figure 9. Optical Molecular Imaging Features
Figure 10. Other Features
Figure 11. Global Clinical Molecular Imaging System Market Size Comparison by Product Forms (2020-2031) & (US$ Million)
Figure 12. PET Scanning Systems Features
Figure 13. Gamma Camera Systems Features
Figure 14. Hybrid Systems Features
Figure 15. Other Features
Figure 16. Global Clinical Molecular Imaging System Market Size by Application (2020-2031) & (US$ Million)
Figure 17. Global Clinical Molecular Imaging System Market Share by Application: 2024 VS 2031
Figure 18. Hospital Case Studies
Figure 19. Clinic Case Studies
Figure 20. Other Case Studies
Figure 21. Clinical Molecular Imaging System Report Years Considered
Figure 22. Global Clinical Molecular Imaging System Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 23. Global Clinical Molecular Imaging System Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 24. Global Clinical Molecular Imaging System Market Share by Region: 2024 VS 2031
Figure 25. Global Clinical Molecular Imaging System Market Share by Players in 2024
Figure 26. Global Clinical Molecular Imaging System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 27. The Top 10 and 5 Players Market Share by Clinical Molecular Imaging System Revenue in 2024
Figure 28. North America Clinical Molecular Imaging System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. North America Clinical Molecular Imaging System Market Share by Country (2020-2031)
Figure 30. United States Clinical Molecular Imaging System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Canada Clinical Molecular Imaging System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Europe Clinical Molecular Imaging System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Europe Clinical Molecular Imaging System Market Share by Country (2020-2031)
Figure 34. Germany Clinical Molecular Imaging System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. France Clinical Molecular Imaging System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. U.K. Clinical Molecular Imaging System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Italy Clinical Molecular Imaging System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Russia Clinical Molecular Imaging System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Ireland Clinical Molecular Imaging System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Asia-Pacific Clinical Molecular Imaging System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Asia-Pacific Clinical Molecular Imaging System Market Share by Region (2020-2031)
Figure 42. China Clinical Molecular Imaging System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Japan Clinical Molecular Imaging System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. South Korea Clinical Molecular Imaging System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Southeast Asia Clinical Molecular Imaging System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. India Clinical Molecular Imaging System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Australia & New Zealand Clinical Molecular Imaging System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Latin America Clinical Molecular Imaging System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Latin America Clinical Molecular Imaging System Market Share by Country (2020-2031)
Figure 50. Mexico Clinical Molecular Imaging System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Brazil Clinical Molecular Imaging System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Middle East & Africa Clinical Molecular Imaging System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Middle East & Africa Clinical Molecular Imaging System Market Share by Country (2020-2031)
Figure 54. Israel Clinical Molecular Imaging System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 55. Saudi Arabia Clinical Molecular Imaging System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 56. UAE Clinical Molecular Imaging System Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 57. Philips Revenue Growth Rate in Clinical Molecular Imaging System Business (2020-2025)
Figure 58. GE Healthcare Revenue Growth Rate in Clinical Molecular Imaging System Business (2020-2025)
Figure 59. Siemens Revenue Growth Rate in Clinical Molecular Imaging System Business (2020-2025)
Figure 60. GMM Revenue Growth Rate in Clinical Molecular Imaging System Business (2020-2025)
Figure 61. Hitachi Revenue Growth Rate in Clinical Molecular Imaging System Business (2020-2025)
Figure 62. United-imaging Revenue Growth Rate in Clinical Molecular Imaging System Business (2020-2025)
Figure 63. Shinva Medical Revenue Growth Rate in Clinical Molecular Imaging System Business (2020-2025)
Figure 64. Kangda Medical Revenue Growth Rate in Clinical Molecular Imaging System Business (2020-2025)
Figure 65. Wandong Medical Revenue Growth Rate in Clinical Molecular Imaging System Business (2020-2025)
Figure 66. Canon Medical Revenue Growth Rate in Clinical Molecular Imaging System Business (2020-2025)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
